BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3526857)

  • 1. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA; Kochsiek K
    Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure.
    Francis GS; Olivari MT; Goldsmith SR; Levine TB; Pierpont G; Cohn JN
    Am Heart J; 1983 Dec; 106(6):1315-20. PubMed ID: 6359844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
    Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
    Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
    Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
    Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J; Hobuss M; Aschenberg W; Tews A
    Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure.
    Bichet DG; Kortas C; Mettauer B; Manzini C; Marc-Aurèle J; Rouleau JL; Schrier RW
    Kidney Int; 1986 Jun; 29(6):1188-96. PubMed ID: 3528612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system.
    Stanek B; Bruckner U; Silberbauer K
    J Hypertens Suppl; 1985 Nov; 3(2):S129-31. PubMed ID: 3003301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
    Manthey J; Osterziel KJ; Röhrig N; Dietz R; Hackenthal E; Schmidt-Gayk H; Kübler W
    Am J Cardiol; 1987 Apr; 59(10):171D-175D. PubMed ID: 2953224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition.
    Naitoh M; Risvanis J; Balding LC; Johnston CI; Burrell LM
    Cardiovasc Res; 2002 Apr; 54(1):51-7. PubMed ID: 12062361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma arginine vasopressin levels in patients with congestive heart failure.
    Goldsmith SR; Francis GS; Cowley AW; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Jun; 1(6):1385-90. PubMed ID: 6343460
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
    Dzau VJ; Swartz SL
    Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.